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Abstract 
Biofilms are slimy substances made up of bacteria that attach to surfaces. Biofilms can be 
found in humans (lung of Cystic Fibrosis patients), natural settings (rocks in streams) and 
man-made environments (medical devices, pipelines). Biofilms are also found in aviation 
fuel tanks, causing physical issues such as clogging in fuel lines and changing the chemical 
makeup of the fuel via bacterial metabolism. Bacterial viruses, known as bacteriophage, 
show potential for reducing biofilms through phage therapy. The goal is to find a phage or 
combination of phage with a broad host range that would be most effective in reducing the 
biofilms of bacteria isolated from fuel tanks. Known phages UT1, SN-T, and PEV2 were 
tested against these biofilms, both individually and in combination. They were tested to 
measure inhibition, in which phage and bacteria were incubated together, and remediation, 
in which biofilms were allowed to preform before the addition of phage. Biofilms were 
assayed for biomass (via crystal violet staining) and viable cell count in the presence of 
phage or combination of phages to determine the amount of biofilm inhibition and 
remediation. Results suggest that the host ranges of UT1, SN-T, and PEV2 were not as 
broad as anticipated, inhibition techniques were more effective than remediation techniques, 
and phage used in combination resulted in greater biofilm reduction than when used singly. 
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Background 
Many types of bacteria are capable of forming a biofilm, which is a community of 
microorganisms attached to a surface1. The formation of a biofilm begins when a free-
floating planktonic cell attaches to a surface. This cell continually divides as others 
gradually attach to this surface, eventually forming microcolonies. These microcolonies 
can be made up of either single bacterial species or mixed species. The structure of the 
biofilm is maintained by the extracellular polymeric substance, or EPS2. Comprised of 
DNA, carbohydrates, polysaccharides, and protein, the EPS protects the bacterial cells 
from environmental factors such as changes in pH, dehydration, and antimicrobial 
agents3. Since biofilms exhibit such a high resistance to antimicrobial agents such as 
antibiotics as well as to the immune system, they may become a source of deep-seated 
and persistent infections4.  
Common infections that typically involve biofilms include urinary tract infections 
(Escherichia coli), septicemia (Streptococcus pneumoniae, E. coli), and lung infections in 
Cystic Fibrosis patients (Pseudomonas aeruginosa)5. Best known as “plaque” in the oral 
cavity, bacterial communities also attach to teeth enamel and dental implants, causing 
dental caries or periodontal diseases such as gingivitis6. In addition to formation in the 
human body, biofilms are found in natural settings, such as streams. Microbes in the 
overlying water assemble on rocks, forming a slimy substance7. Biofilms may even be 
found in man-made environments, including hospital devices and pipelines. For example, 
with many surgical implants, infections stemming from biofilm formation cannot solely 
be treated by antimicrobial therapy. Only complete removal of the implant allows the 
infection to be treated8.  
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Due to the ineffectiveness of traditional methods in reducing the highly resistant 
biofilms, the use of phage therapy has become an important research area. Phage therapy 
is the use of bacteriophage, bacteria specific viruses, for the treatment of bacterial 
infections. Bacteriophages kill bacteria by inducing bacterial lysis. In this process, phages 
attach to the cell surface and inject their genetic material into the cell. Phage DNA is 
synthesized within the cell, eventually leading to the production of phage head, tail, and 
lysis proteins9. These components assemble into hundreds of phages and burst, or lyse, 
the cell. These new phages then infect and kill surrounding bacterial cells. Phage therapy 
for human infections first found application in the 1920s and 1930s. However, with the 
discovery of sulfa and penicillin drugs in the 1940s, phage therapy was set aside. While 
antibiotic drugs have been quite successful in treating infections in the intervening 
decades, the rapid spread of antibiotic-resistant bacteria in the past two decades has 
caused a resurgence of interest in phage therapy. Some researchers have already 
conducted studies using phage therapy to reduce biofilm count on medical catheters. 
They found that pre-treating catheters reduced biofilm count by nearly a three-log 
reduction (99.9% decrease), while treating the catheters immediately after bacterial 
inoculation resulted in just over a two-log reduction (99%)10. 
This study focuses on biofilms that form in aviation jet fuel tanks, which result in 
a number of problems. Biofilms can cause clogging of thin fuel lines, changes in the 
chemical makeup of jet fuel, and even corrosion of fuel system infrastructures. We 
propose to treat these biofilms with bacteriophage, using PAO1 as our model organism. 
PAO1 is a strain of P. aeruginosa that can grow using jet fuel as its sole carbon source. 
Ripp and Miller determined that the phage UT1, isolated from natural freshwater, was 
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effective at reducing P. aeruginosa biofilms11. Their data suggests that, under starvation 
conditions, UT1 adopts a pseudolysogenic cycle. The process of pseudolysogeny is one 
of survival, as the development of a bacteriophage is stalled when conditions are not 
optimal12. Another study also found phage PEV2, isolated from a sewage treatment plant, 
to be effective against P. aeruginosa13.  PEV2 is an obligatorily lytic phage that can 
infect PAO1 both aerobically and anaerobically. Finally, the phage SN-T was also 
isolated from a sewage plant, but with Sphaerotilus natans as its host14. It was more 
closely examined due to its ability to form plaques on multiple bacterial hosts. The ability 
to infect multiple bacterial hosts makes it particularly interesting for phage therapy. Our 
goal is determine which of these three phage types, alone or in combination, is most 
effective in preventing or reducing the biofilms in an experimental system. 
 
 
  
P a g e  | 5 
 
Materials and Methods  
 
Fuel Isolate Screening 
A library of bacteria isolated from aviation fuels (Table 1) was screened by the 
spot lysis test for susceptibility to phages UT1, SN-T, and PEV2. Each bacterium was 
grown on a Luria Bertani broth (LB) agar plate. After distinct colonies formed, a single 
colony was taken from the plate using a sterile inoculating loop and deposited in a sterile 
test tube with 4 mL of LB broth. The tube was capped loosely, placed on a gyratory 
shaker at 180 RPM, and allowed to grow overnight in a 37°C incubator. The following 
day, if the overnight culture was cloudy, 100 μL of the overnight culture was added to 4 
mL of melted LB top agar and mixed by vortexing. The mixture was immediately poured 
over an LB agar plate pre-warmed to 37°C. After the top agar solidified, 10 μL of each 
bacteriophage UT1 (1.15x1011 plaque forming units (PFU)/mL), SN-T (3.19x109 
PFU/mL), and PEV2 (7.2x109 PFU/mL) were spotted onto the bacterial lawn. Two plates 
were made for each fuel isolate sample: one incubated at room temperature (RT) and one 
at 37°C. The following day, the plates were observed for phage-induced lysis. 
 
Efficiency of Plating 
 To distinguish between lysis from without (when the bacterial cell membrane is 
overwhelmed by phages) and true infection, each fuel isolate that exhibited lysis in the 
screening phase (Table 1) was tested for the efficiency of plating (EOP) by that phage. 
When there was more than a single isolate of a genus, we tested one for EOP (e.g., only 
one Bacillus sp. isolate of the five in Table 1 was tested for EOP). As described above, an 
overnight culture of each bacterium was used to make a lawn and allowed to solidify in 
duplicate. In a 96-well plate, stocks of UT1, SN-T, and PEV2 were serially diluted to 102 
P a g e  | 6 
 
PFU/mL. The last six dilutions (102-107 PFU/mL) of each were spotted onto the bacterial 
host lawn in 10 μL aliquots. The original, undiluted stock cultures of phage were also 
spotted. Several of the bacteria that appear in Table 2 were not used, as some were the 
same genus. 
 
Biofilm Assay 
 Only P. aeruginosa PAO1 was used for the 16-hour biofilm assay. Two variants 
of this procedure were performed: 1) phage was added at the same time as the bacterial 
inoculum (inhibition), and 2) biofilms were allowed to form before the addition of phage 
(remediation).  
Inhibition 
To each well of a sterile 96-well plate, 200 μL of mixture containing PAO1 at 1x105 
colony forming units/mL or PAO1 at 1x105 CFU/mL with phage at a multiplicity of 
infection (MOI) of 100 was added. For wells containing multiple phages, the total MOI 
was 100, being composed of equal parts of each phage in the mixture. Plates were 
incubated at 37°C for exactly 16 hours without shaking.  
Remediation 
To each well of a sterile 96-well plate, 200 μL of mixture containing PAO1 at 1x105 
CFU/mL was added and then incubated at 37°C for exactly 16 hours without shaking. At 
16 hours, the supernatant was removed from each well and 200 μL of MSG or MSG with 
phage at 1x107 PFU/mL was added to the appropriate well. For wells containing multiple 
phages, the total PFU/mL was 1x107, being composed of equal parts of each phage in the 
mixture. The plate was then incubated for 24 hours at 37°C without shaking. 
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Crystal Violet Stain 
To determine the biomass formed in each well, 50 μL of crystal violet stain was 
added to each well and incubated at room temperature for thirty minutes. The plate was 
carefully washed with MilliQ (purified) water and allowed to dry overnight. The next 
day, 200 μL of 97.5% ethanol was added to each well and incubated at room temperature 
for ten minutes to extract the crystal violet from the biofilms. 150 μL of this crystal violet 
extract was transferred to a new 96-well plate, and absorbance was measured using a 
plate reader at 590 nm. 
 
Viable Cell Counts 
 To determine the number of viable cells attached to the well surface, the 
supernatant from the wells was removed, 200 μL of fresh MSG was added to each well, 
and the biofilm was mechanically resuspended using a pipet tip. The resuspended 
biofilms were serially diluted and plated on LB agar according to the drop plate 
method15. Plates were incubated overnight at 37°C and results were reported as colony 
forming units (CFU) per centimeter2. 
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Results 
 Of the 59 bacteria isolated from fuel, 30 showed some degree of susceptibility to 
phage (Table 1). There were a few instances in which there was a different degree of 
clearing for the same bacterium at different temperatures. Burkholderia cepacia (#70) did 
not have any clearing from SN-T at 37°C but had substantial haziness at room 
temperature (RT); a Microbacterium (#81) had a similar result when exposed to UT1. 
Both a Staphylococcus sp. (#78) and an unknown bacterial isolate (#94) showed 
substantial haziness at 37°C and clearing with a hazy background at RT for phage SN-T 
and PEV2. The other cases that showed differing results between temperatures (#71, 72, 
76, 77, 109) had greater degrees of clearing at 37°C than at RT. SN-T and PEV2 
displayed a broader range of activity, affecting 29 and 22 isolates, respectively, while 
UT1 only affected 12.  
 In order to ensure that these results were due to true infection from the phage and 
not lysis from without, the efficiency of plating (EOP) test was performed. Of bacterial 
isolates that showed susceptibility in the spot lysis assay, a representative from each 
genus was subjected to EOP (Table 2). If no lysis occurred in any of the dilutions, we 
concluded that the results of the screening were due to lysis from without and the 
bacterium was not used in the 16-hour biofilm assay. Unfortunately, none of the fuel 
isolates showed susceptibility to phage at lower concentrations (Table 2). As a result, 
biofilm inhibition and remediation trials with phages UT1, SN-T, and PEV2 were done 
solely with PAO1. 
 Crystal violet staining was used as an estimate of biofilm biomass where greater 
absorbance from crystal violet was equated with greater biomass. The results for 
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inhibition tests in Figure 2 showed that SN-T (fold change of -0.2812 ±0.02389), PEV2 (-
0.3951 ±0.06932), UT1/PEV2 (-0.5104 ±0.03419), SN-T/PEV2 (-0.4280 ±0.03490), and 
UT1/SN-T/PEV2 (-0.7395 ±0.02276) treatments significantly reduced biomass of PAO1 
biofilms formed in 96-well plates. UT1 and UT1/SN-T, with statistically significant 
changes, had an increase in biomass. These UT1 and UT1/SN-T results parallel those 
from the remediation trials (Figure 3) in which treatment with UT1/SN-T, UT1/PEV2, 
SN-T/PEV2, and UT1/SN-T/PEV2 resulted in statistically significant increases in 
biomass. Individual treatments of UT1, SN-T, and PEV2 were statistically similar to the 
PAO1 control. In the remediation trial, no decrease in biomass was observed. 
 As crystal violet estimates biofilm biomass, which is composed not only of cells 
but also the EPS, viable cell counts were also performed to account for possible 
differences in EPS resulting from phage treatment. Indeed it was found that viable cell 
counts yielded different results from crystal violet. The inhibition results (Figure 4) 
showed that UT1 (log reduction -1.107 ±0.1695), PEV2 (-2.664 ±0.001968), UT1/SN-T 
(-0.08951 ±0.2073), UT1/PEV2 (-2.526 ±0.1883), SN-T/PEV2 (-2.580 ±0.01864), and 
UT1/SN-T/PEV2 (-2.628 ±0.02232) treatments significantly reduced the number of 
living cells. For example, PEV2 displayed almost a three-log reduction compared to the 
PAO1 control, which is about a 99.9% reduction. In other words, the number of viable 
cells in wells with PEV2 treatments is about 1000 times smaller than those in the PAO1 
control wells. However, when phages were applied to an already established PAO1 
biofilm in the remediation assay (Figure 5), there were no statistically significant 
differences between any treatment and the control, i.e. no reduction in the number of live 
cells in the PAO1 biofilms.  
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Discussion 
The advantage of phage therapy is its self-replicating nature of infection. The 
hope was to use a small amount of phage to reduce a large amount of biofilm. 
Additionally, finding a broad-host range phage would be extremely advantageous, since 
most biofilms are mixed-species. Past studies suggest that these bacteriophages play a 
key role in phage ecology and gene transfer in nature12. If a broad-host range phage 
cannot be utilized, each bacterium in the biofilm would require its own phage and 
efficiency would be reduced. 
With the initial fuel isolate screening, not all bacteria were susceptible to the 
phage tested, and those that were showed different degrees of clearing. This was not 
unexpected as bacteriophages can be very specific for a bacterial host, and even those 
that exhibit broader host ranges do not infect all bacterial genera. From the efficiency of 
plating tests, it was determined that initial susceptibility was not due to true infection. If a 
true infection occurred, the bacterial lawns would be affected at lower concentrations of 
the phage and individual plaques would have been observed. One possible reason cell 
death occurred only by a high concentration of phage is lysis from without. During this 
process, the sheer number of phage attached to the cell membrane causes leaky junctions, 
eventually destroying it without the formation of new phage16. 
 Although previous studies have shown that UT1, SN-T, and PEV2 exhibit a broad 
host-range, they could not utilize any of the bacterial isolates in this study as hosts. These 
bacteria may lack the receptor(s) necessary for the phage to gain entry or may have 
evaded infection through other means such restriction modification systems (destroying 
phage genetic material before replication), or programmed cell death. Under the 
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conditions tested, phage cocktails appeared to be most effective. Additionally, phages 
were more effective at inhibiting biofilm formation than at remediating biofilms. 
Some of the results from the crystal violet absorbance readings were unexpected. 
Though some decrease in biomass was observed, UT1 and UT1/SN-T treatments in 
inhibition testing and UT1/SN-T, UT1/PEV2, SN-T/PEV2, and UT1/SN-T/PEV2 
treatments in remediation testing led to an increase in absorbance. This increase may 
have been a result of cell debris, phage biomass, or DNA, carbohydrates, and 
polysaccharides from the EPS. However, the increased biomass was not indicative of the 
number of living cells still attached to the well wall. In the inhibition trials, wells treated 
with UT1 nearly doubled in biomass compared to the PAO1 uninfected control, yet, 
when the viable cell number was determined, there was a one-log reduction from the 
control, a statistically significant decrease. On the other hand, there was a significant 
reduction in biomass with SN-T treatment, but no statistically significant change in the 
number of live cells.   
While under current conditions phage treatment was unable to reduce biomass of 
viable cell number of established PAO1 biofilms, several modifications to the testing 
methods might be considered. First, allowing phage to incubate longer with the formed 
biofilms, where the EPS is well established, might determine if the phages need 
additional time to diffuse through the EPS or to replicate and lyse the cells. Another 
approach might be to use the phages in combination with chemical compounds that break 
down the protective EPS, allowing phages greater access to bacterial cells. This process 
could also be faster than the prior, as the phages could diffuse into the bacterial cells 
much more quickly. Finally, it would be beneficial to test the best-performing phage 
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cocktails in a fuel model system. It is possible that the susceptibility of bacteria to phages 
is entirely different in the presence of fuel or confined space rather than the wells of a 
plastic plate. On the other hand, the fuel could actually be detrimental to phage structure 
and destroy them before they even have a chance to attach to the bacterial cell membrane.  
Our study has demonstrated 1) combinations of phages inhibit biofilm formation 
to a greater extent than phage used singly and 2) under the conditions tested, phage 
therapy was more effective in preventing biofilm formation than it was in remediating 
established biofilms. While the phages tested did not exhibit the broad-host range activity 
expected, novel phages could be isolated that pose this activity. Overall, phage therapy 
appears to be a promising method of reducing bacterial biofilms in aviation fuel systems. 
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Tables and Figures 
Table 1. Bacterial isolates from aviation fuel tanks tested for susceptibility to phages 
UT1, SN-T, and PEV2. Numbers represent differing degrees of susceptibility to the 
phage. 0= no clearing, 1= formation of individual plaques, 2= substantial haziness 
throughout the cleared zone, 3= clearing throughout with a faintly hazy background, and 
4= complete clearing. Those with two numbers had different results at 37°C/room 
temperature. 
Organism  Plate ID #  UT1  SN‐T  PEV‐2 
?  7  0  0  0 
Clostridium sporosphaeroides  9  0  0  0 
Indeterminate  11  0  0  0 
?  12  0  0  0 
?  14  0  0  0 
?  15  0  0  0 
Methylobacterium  18  0  0  0 
Clostridium  19  0  0  0 
Curtobacterium  21  0  0  0 
?  22  0  0  0 
?  23  0  0  0 
?  24  0  0  0 
?  25  0  0  0 
Staphylococcaceae  27  0  0  0 
Curtobacterium  30  0  0  0 
Mycobacterium  31  0  0  0 
?  32  0  0  0 
?  34  0  0  0 
?  35  0  0  0 
Burkholderia  36  NT  NT  NT 
Propioribacterium acnes  38  NT  NT  NT 
Burkholderia  40  2  0  0 
Rahnella aquatillis  41  0  0  0 
?  42  0  0  0 
?  43  0  0  0 
Staphylococcaceae  45  0  3  3 
Mycobacterium  47  0  2  2 
Mold  49  0  0  0 
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Burkholderia  50  0  2  0 
Rhodococcus equi  51  0  0  0 
?  52  0  0  0 
Staphylococcaceae  54  0  0  0 
Arthrobacter 
nitroguajacolicus  56  0  2  0 
Rothia amarae  58  2  2  0 
Staphylococcus epidermis  59  3  3  0 
Arthrobacter 
nitroguajacolicus  63  0  2  0 
Microbacterium  64  0  2  0 
Staphylococcaceae  66  2  2  2 
Staphylococcaceae  67  3  3  3 
Undetermined   68  2  2  2 
Burkholderia cepacia  70  0  "0/2"  0 
Indeterminate  71  2  "4/2"  "4/2" 
Microbacterium  72  "0/2"  "4/2"  "4/2" 
Bacillus  76  2  "4/2"  "4/2" 
Bacillus  77  2  "4/2"  "4/2" 
Staphylococcus  78  3  "2/3"  "2/3" 
Bacillus  79  0  2  2 
Curtobacterium  80  0  4  4 
Microbacterium  81  2  3  3 
Staphylococcus  82  0  3  3 
Fungus  83  0  2  2 
Unable to clone  94  0  "2/3"  "2/3" 
Bacillus  97  0  2  2 
Bacillus  100  0  0  0 
Bacillus  101  0  2  2 
Microbacterium  102  0  2  2 
Microbacterium  103  0  2  2 
Staphylococcus  107  0  3  3 
Micrococcus  109  0  "4/3"  "4/3" 
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Table 2. Efficiency of plating results for bacterial fuel isolates that showed some degree 
of susceptibility to phages UT1, SN-T, and PEV2.  
Organism  Plate ID # 
Individual plaques 
(Y/N) 
Burkholderia  50  N 
Arthrobacter nitroguajacolicus  56  N 
Rothia amarae  58  N 
Staphylococcus epidermis  59  N 
Bacillus  76  N 
Bacillus  77  N 
Staphylococcus  78  N 
Microbacterium  81  N 
Bacillus  101  N 
Staphylococcus  107  N 
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Figure 1. Efficiency of plating results for #101, Bacillus sp. compared to the PAO1 
control. Absence of individual plaques indicates that clearing in the spot lysis assay was 
not due to true infection. Similar results were found for all fuel isolates tested. 
  
PAO1 Bacillus sp. 
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Figure 2. Fold change in crystal violet absorbance for inhibition biofilm assays compared 
to the PAO1 control. Treatment results with the same letter are not statistically 
significantly different. Those with different letters have statistically significant 
differences in biomass.  
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Figure 3. Fold change in crystal violet absorbance for remediation biofilm assays 
represented as fold change compared to the PAO1 control. Treatment results with the 
same letter are not statistically significantly different. Those with different letters have 
statistically significant differences in biomass.  
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Figure 4. Colony-forming units (CFU) per cm2 of PAO1 biofilms from inhibition assays. 
The number of live cells that remain attached to the well surface is represented on a log10 
scale. Treatment results with the same letter are not statistically significantly different. 
Those with different letters have statistically significant differences in CFU/cm2.
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Figure 5. Colony-forming units (CFU) per cm2 of PAO1 biofilms from remediation 
assays. The number of live cells that remain attached to the well surface is represented on 
a log10 scale. Treatment results with the same letter are not statistically significantly 
different. Those with different letters have statistically significant differences in 
CFU/cm2. 
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